SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 725.62+3.0%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Felix B who wrote (2312)2/19/2018 3:30:55 PM
From: Miljenko Zuanic   of 3559
 
I do not know. IF it is signed as "completed", at least all data collection are completed and forwarded for analysis (which should took 2-3 weeks). I do think they did have data (at least primary analysis) at CC. Sanofi and REGN indicated that marketing expense related to Praluent promotion will accelerate in 2018, so they "expected" positive results.

Maybe they want maximum impact at Conference, to break Repatha dominance. Still that does not add to good SH-relation and conducts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News